Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-075074

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jack A. Khattar
Officer — President, CEO · Director
Period of report
Dec 22, 2017
Accepted (ET)
Dec 26, 2017 · 6:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Dec 22, 2017G250$0.00D450,154D
Common StockDec 22, 2017G250$0.00D449,904D
Common StockDec 22, 2017G250$0.00D449,654D
Common StockDec 22, 2017G250$0.00A2,500IBy son
Common Stockholding———1,089,750IBy the KBT Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses